MESO

MESOBLAST LTD

MESO·590717401·US·ADR·Healthcare - Biotechnology-13D/G

MESO (MESOBLAST LTD) is held by 42 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($9.7M), MORGAN STANLEY ($7.9M), GOLDMAN SACHS GROUP INC ($6.1M). Net institutional sentiment: Mixed.

42
Holders
Avg rating(12 Elite)
$44.6M
Total Value
59% (48)
Fund Consensus
24 buying - 17 selling
MESOSmart Money Verdict
View all
Held by 42 funds
12 elite
Who's Trading
InsiderGGGeorge GregoryBuy $3.4MApr 10, 2026
InsiderGGGeorge GregoryBuy $14KApr 9, 2026
InsiderGGGeorge GregoryBuy $7KApr 9, 2026
InsiderGGGeorge GregoryBuy $7KApr 9, 2026
InsiderGGGeorge GregoryBuy $14KApr 9, 2026
InsiderGGGeorge GregoryBuy $29KApr 9, 2026
InsiderGGGeorge GregoryBuy $7KApr 9, 2026
InsiderGGGeorge GregoryBuy $14KApr 9, 2026
ActivistGGGeorge, Gregory22.4%Mar 11, 2026
ActivistGWGueck William J.5.0%Sep 16, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
630,855(-6.7%)$9.7M0.0%-24.85%
0
Decreased
514,431(-13.8%)$7.9M0.0%+1.29%
0
Increased
397,215(+0.3%)$6.1M0.0%+32.34%
27
Decreased
386,472(-10.1%)$5.9M0.0%+10.96%
0
Increased
132,573(+82.7%)$2M0.0%-6.85%
40
Increased
100,004(+608.4%)$1.5M0.0%+4.06%
41
Decreased
98,786(-41.0%)$1.5M0.0%-14.02%
0
Decreased
85,959(-34.6%)$1.3M0.0%-16.90%
0
New
83,915$1.3M0.0%+6.12%
35
New
59,100$886,5000.0%+6.12%
34
Increased
49,617(+1.8%)$763,1090.0%+45.93%
25
Increased
40,918(+227.3%)$629,3190.0%+2.94%
39
Decreased
39,802(-30.9%)$612,1550.0%+1.98%
0
Increased
34,042(+83.2%)$523,5660.0%+7.46%
37
Increased
33,747(+9.8%)$519,0280.0%+8.73%
18
Increased
26,946(+45.6%)$414,4290.0%-10.85%
32
Increased
26,463(+0.3%)$407,0010.0%-25.80%
24
Increased
26,266(+22.5%)$404,0000.0%+22.98%
29
Increased
25,344(+0.5%)$389,7910.0%+7.64%
24
Unchanged
18,093$278,2700.0%+128.10%
0

Showing 1-20 of 48

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used